Primary Cell Culture Market Size & Share – Trends Report, 2032

Primary Cell Culture Market - By Cell Type (Animal, Human), Component (Products [Blood, Bone Marrow, Endothelial], Media, Reagents & Supplements), Application (Vaccine Production, Cell & Gene Therapy Development), End-user – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp;Research approach

1.2.2&nbsp;&nbsp;&nbsp;Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp;Base year calculation

1.3.2&nbsp;&nbsp;&nbsp;Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp;Primary sources

1.5.2&nbsp;&nbsp;&nbsp;Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp;Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising usage of primary cell culture products in in-vitro testing

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing prevalence of cancer and other persistent health conditions

3.2.1.3&nbsp;&nbsp;&nbsp; Growing advancement in genetic engineering protocols

3.2.1.4&nbsp;&nbsp;&nbsp; Increase in funding for functional biology and research

3.2.2&nbsp;&nbsp;&nbsp;Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Ethical and regulatory concerns related to the use of primary cells

3.2.2.2&nbsp;&nbsp;&nbsp; Limitations associated with primary cells

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cell Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Animal cells

5.3&nbsp;&nbsp;&nbsp; Human cells

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Component, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Products

6.2.1&nbsp;&nbsp;&nbsp;Blood cell

6.2.2&nbsp;&nbsp;&nbsp;Nerve cell

6.2.3&nbsp;&nbsp;&nbsp;Bone marrow

6.2.4&nbsp;&nbsp;&nbsp;Endothelial cell

6.2.5&nbsp;&nbsp;&nbsp;Skin cell

6.2.6&nbsp;&nbsp;&nbsp;Muscle cell

6.2.7&nbsp;&nbsp;&nbsp;Other cell types

6.3&nbsp;&nbsp;&nbsp; Media

6.4&nbsp;&nbsp;&nbsp; Reagents &amp; supplements

6.4.1&nbsp;&nbsp;&nbsp;Cell dissociation and cell attachment solutions

6.4.2&nbsp;&nbsp;&nbsp;Buffers and salts

6.4.3&nbsp;&nbsp;&nbsp;Cell freezing media

6.4.4&nbsp;&nbsp;&nbsp;Sera, growth factors &amp; cytokines

6.4.5&nbsp;&nbsp;&nbsp;Other reagents &amp; supplements

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Drug screening and toxicity testing

7.3&nbsp;&nbsp;&nbsp; Vaccine production

7.4&nbsp;&nbsp;&nbsp; Cell &amp; gene therapy development

7.5&nbsp;&nbsp;&nbsp; Regenerative medicine

7.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-User, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pharmaceutical and biotechnology companies

8.3&nbsp;&nbsp;&nbsp; Research institutes and academic laboratories

8.4&nbsp;&nbsp;&nbsp; Contract research organizations (CROs)

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp;U.S.

9.2.2&nbsp;&nbsp;&nbsp;Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp;Germany

9.3.2&nbsp;&nbsp;&nbsp;UK

9.3.3&nbsp;&nbsp;&nbsp;France

9.3.4&nbsp;&nbsp;&nbsp;Spain

9.3.5&nbsp;&nbsp;&nbsp;Italy

9.3.6&nbsp;&nbsp;&nbsp;Netherlands

9.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp;Japan

9.4.2&nbsp;&nbsp;&nbsp;China

9.4.3&nbsp;&nbsp;&nbsp;India

9.4.4&nbsp;&nbsp;&nbsp;Australia

9.4.5&nbsp;&nbsp;&nbsp;South Korea

9.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp;Brazil

9.5.2&nbsp;&nbsp;&nbsp;Mexico

9.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp;Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp;South Africa

9.6.3&nbsp;&nbsp;&nbsp;UAE

9.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles 

10.1&nbsp;&nbsp;&nbsp; BioLamina AB

10.2&nbsp;&nbsp;&nbsp; Corning Incorporated

10.3&nbsp;&nbsp;&nbsp; Creative Bioarray

10.4&nbsp;&nbsp;&nbsp; Cyagen

10.5&nbsp;&nbsp;&nbsp; FUJIFILM Wako Pure Chemical Corporation

10.6&nbsp;&nbsp;&nbsp; Kosheeka

10.7&nbsp;&nbsp;&nbsp; Lifeline Cell Technology,

10.8&nbsp;&nbsp;&nbsp; Lonza Bioscience

10.9&nbsp;&nbsp;&nbsp; Merck KGaA

10.10&nbsp;&nbsp;&nbsp; PELOBIOTECH GmbH

10.11&nbsp;&nbsp;&nbsp; PromoCell GmbH

10.12&nbsp;&nbsp;&nbsp; STEMCELL Technologies

10.13&nbsp;&nbsp;&nbsp;Thermo Fisher Scientific Inc.

&nbsp;&nbsp;&nbsp;

Primary Cell Culture Market

Get a free sample of this report